Department of Pharmacy Practice, University of Illinois Chicago, Chicago, IL, United States.
Department of Medicine, University of Illinois Chicago, Chicago, IL, United States.
Am J Clin Nutr. 2023 Apr;117(4):717-730. doi: 10.1016/j.ajcnut.2023.01.018. Epub 2023 Feb 1.
The microbiome-gut-brain-axis (MGBA) is emerging as an important mechanistic link between diet and mental health. The role of significant modifiers of the MGBA, including gut microbial metabolites and systemic inflammation, in individuals comorbid with obesity and mental disorders, is under-investigated.
This exploratory analysis examined associations among microbial metabolites-fecal SCFAs, plasma inflammatory cytokines, and diet with depression and anxiety scores in adults comorbid with obesity and depression.
Stool and blood were obtained from a subsample (n = 34) of participants enrolled in an integrated behavioral intervention for weight loss and depression. Pearson partial correlation and multivariate analyses determined associations among changes in fecal SCFAs (propionic, butyric, acetic, and isovaleric acids), plasma cytokines [C-reactive protein, interleukin 1 beta, interleukin 1 receptor antagonist (IL-1RA), interleukin 6, and TNF-α], and 35 dietary markers over 2 mo, and changes in SCL-20 (Depression Symptom Checklist 20-item) and GAD-7 (Generalized Anxiety Disorder 7-Item) scores over 6 mo.
Changes in the SCFAs and TNF-α at 2 mo were positively associated (standardized coefficients: 0.06-0.40; 0.03-0.34) with changes in depression and anxiety scores at 6 mo, whereas changes in IL-1RA at 2 mo were inversely associated (standardized coefficients: -0.24; -0.05). After 2 mo, changes in 12 dietary markers, including animal protein, were associated with changes in SCFAs, TNF-α, or IL-1RA at 2 mo (standardized coefficients: -0.27 to 0.20). Changes in 11 dietary markers, including animal protein, at 2 mo were associated with changes in depression or anxiety symptom scores at 6 mo (standardized coefficients: -0.24 to 0.20; -0.16 to 0.15).
Gut microbial metabolites and systemic inflammation may be biomarkers of importance within the MGBA, linking dietary markers, such as animal protein intake, to depression and anxiety for individuals with comorbid obesity. These findings are exploratory and warrant replication.
肠道微生物群-肠道-大脑轴(MGBA)作为饮食与心理健康之间的重要机制联系正在出现。在肥胖和精神障碍共病患者中,MGBA 的重要调节剂(包括肠道微生物代谢物和全身炎症)的作用尚未得到充分研究。
本探索性分析研究了肠道微生物代谢物-粪便短链脂肪酸(SCFAs)、血浆炎症细胞因子和饮食与肥胖和抑郁症共病成年人的抑郁和焦虑评分之间的关联。
从参加减肥和抑郁综合行为干预的参与者的亚样本(n=34)中获得粪便和血液。皮尔逊偏相关和多变量分析确定了在 2 个月内粪便 SCFAs(丙酸、丁酸、乙酸和异戊酸)、血浆细胞因子[C 反应蛋白、白细胞介素 1β、白细胞介素 1 受体拮抗剂(IL-1RA)、白细胞介素 6 和 TNF-α]和 35 种饮食标志物的变化与 6 个月内 SCL-20(抑郁症状检查表 20 项)和 GAD-7(广泛性焦虑症 7 项)评分变化之间的关联。
在 2 个月时 SCFAs 和 TNF-α 的变化与 6 个月时抑郁和焦虑评分的变化呈正相关(标准化系数:0.06-0.40;0.03-0.34),而在 2 个月时 IL-1RA 的变化呈负相关(标准化系数:-0.24;-0.05)。在 2 个月后,12 种饮食标志物(包括动物蛋白)的变化与 2 个月时 SCFAs、TNF-α 或 IL-1RA 的变化相关(标准化系数:-0.27 至 0.20)。在 2 个月时的 11 种饮食标志物(包括动物蛋白)的变化与 6 个月时抑郁或焦虑症状评分的变化相关(标准化系数:-0.24 至 0.20;-0.16 至 0.15)。
肠道微生物代谢物和全身炎症可能是 MGBA 中重要的生物标志物,将饮食标志物(如动物蛋白摄入)与肥胖和精神障碍共病患者的抑郁和焦虑联系起来。这些发现是探索性的,需要复制。